Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Alopecia Secondary to Endocrine Therapy in Postmenopausal Women With Breast Cancer

NCT01300871 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT01300871
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01300871 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Alopecia Secondary to Endocrine Therapy in Postmenopausal Women With Breast Cancer
Lead sponsor
University Health Network, Toronto
Phase
Observational
Overall status
Terminated
Start date
January 31, 2011
Completion date
January 31, 2012
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer